Kidney Denervation: Latest Breakthroughs and Insights.

Area of Science:

• Cardiovascular Medicine
• Interventional Cardiology
• Nephrology

Background:

• Uncontrolled hypertension is a growing global health concern.
• Kidney denervation, a minimally invasive procedure, ablates renal sympathetic nerves.
• Recent FDA approval highlights its emergence as an interventional treatment option.

Purpose of the Study:

• To evaluate the current status of kidney denervation for hypertension management.
• To identify patient populations and predictive biomarkers for treatment response.
• To discuss the role of multidisciplinary teams in shared decision-making for kidney denervation.

Main Methods:

• Review of clinical trial data on kidney denervation safety and efficacy.
• Analysis of patient populations excluded from pivotal trials (e.g., advanced CKD, kidney transplant recipients).
• Discussion of ongoing and future research directions.

Main Results:

• Kidney denervation is generally safe, but efficacy data are mixed.
• Optimal patient selection and prediction of blood pressure response remain unclear.
• Key populations like those with advanced CKD were excluded from trials.

Conclusions:

• Kidney denervation shows promise as an adjunct therapy for hypertension.
• Further research is crucial to define its long-term safety, efficacy, and ideal patient candidates.
• Shared decision-making involving multidisciplinary teams is essential for appropriate patient selection.